Saltar al contenido
Merck

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2 application for HPLC

Materiales

columna analítica

Referencia del producto
Descripción
Precios

Columna para HPLC quiral Astec® CHIROBIOTIC® V2

5 μm particle size, L × I.D. 25 cm × 4.6 mm

CONDITIONS

column

CHIROBIOTIC V2, 25 cm x 4.6 mm I.D., 5 μm particles (15024AST)

mobile phase

15 mM ammonium formate in methanol

flow rate

1 mL/min

column temp.

25 °C

detector

UV, 230 nm

injection

10 μL

sample

1 mg/mL in methanol

Descripción

Nota de análisis

Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The (R) enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V2 successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.

Información legal

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC